MedPath

IDROP, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:1
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 2
1 (50.0%)

A Clinical Study to Assess the Efficacy and Safety of SED80 for Use in Cataract Surgery

Phase 2
Completed
Conditions
Cataract in Inflammatory Ocular Disorders
Interventions
Drug: Placebo Dose 1
Drug: Placebo Dose 2
First Posted Date
2021-01-15
Last Posted Date
2021-01-15
Lead Sponsor
iDrop, Inc.
Target Recruit Count
60
Registration Number
NCT04711213
Locations
🇸🇻

Centre De. Oftalmologia, San Salvador, El Salvador

A Clinical Study to Assess the Efficacy and Safety of Dexamethasone Suspension for Cataract Surgery

Phase 1
Completed
Conditions
Inflammation Eye
Interventions
First Posted Date
2018-09-27
Last Posted Date
2019-05-24
Lead Sponsor
iDrop, Inc.
Target Recruit Count
60
Registration Number
NCT03687931
Locations
🇺🇸

Arizona Eye Center, Chandler, Arizona, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.